HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Unilever Hit With Suit For Negligent Marketing, Recall Of Hair Smoother

This article was originally published in The Rose Sheet

Executive Summary

Suit filed in New Jersey state court alleges that Unilever PLC’s marketing for a Suave hair-smoothing kit was deceptive and the firm’s response to reports of adverse reactions was insufficient. Unilever says it has recalled the product and notes that complaints made up only a “small percentage” of total product shipped.

You may also be interested in...

US Proposed Class Action: Preservative Choice Makes Unilever’s TRESemme Keratin Products ‘Defective’

The presence of formaldehyde releaser DMDM hydantoin in TRESemme Keratin shampoos pose undisclosed risks of hair loss and/or scalp irritation, as shown by hundreds of consumer complaints online, plaintiffs allege in proposed class actions filed in Illinois and New Jersey federal courts.

Unilever To Create $10 Mil. Settlement Fund For Suave Hair-Smoother Ills

Unilever settles class-action suits in three states related to alleged injuries from use of its Suave Professionals Keratin Infusion 30-Day Smoothing Kit, which plaintiffs claim was a powerful chemical relaxer rather than a non-toxic conditioning system as advertised. The firm will establish funds totaling more than $10 million to reimburse consumers for purchases and medical expenses.

FDA Enforcement Priorities: Eye Products, Dual Drug/Cosmetic Firms

When FDA inspects a facility producing both drugs and cosmetics, the manufacturer should be using one standard and that’s the drug standard, says Karyn Campbell, director of the investigations branch at FDA’s Philadelphia District Office.

Related Content


Related Companies




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts